The method was successfully applied to identify: four SNPs associated with the risk of hemostasis disorders [71] and three SNPs in gene of melanocortin-1 receptor (MC1R), associated with melanoma and non-melanoma skin cancer risk [72,73]. Here, MC1R is linked to skin neoplasm.